Marty Moore

Senior Consultant, GxPAssure

Martin Moore is a highly experienced pharmaceutical quality and manufacturing specialist; Martin Moore brings nearly four decades of industry expertise and over twenty five years in senior leadership roles. He is recognised for his ability to evaluate and manage complex operational and compliance risks across global manufacturing environments, with a focus on leadership effectiveness, organisational culture, strategic alignment, internal controls, supply chain resilience, and evolving business needs.

Martin has a strong track record in site remediation, having successfully supported facilities operating under FDA Consent Decrees, Warning Letters, critical MHRA findings, and other adverse regulatory outcomes. His expertise includes the design and optimisation of Quality Management Systems, leadership of quality and data integrity investigations, establishment of data governance frameworks, and implementation of robust GxP compliance strategies.

He has conducted extensive audit programmes—spanning manufacturing site audits, Due Diligence assessments, and inspection readiness activities—and has prepared numerous facilities for PrePAI, FDA, MHRA, EMA, and RestofWorld regulatory inspections. Martin is also highly experienced in developing comprehensive and effective responses to regulatory observations.

His technical background encompasses APIs, terminally sterilised and aseptically filled products, biopharmaceuticals, vaccines, topical formulations, liquids, and solid-dose manufacturing. Martin’s depth of experience, combined with his strategic approach to quality risk management and regulatory compliance, positions him as a trusted specialist in driving sustainable quality performance across the pharmaceutical sector.